Cognitive Impairment
891
154
207
420
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
89 trials with published results (10%)
Research Maturity
420 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
38 terminated out of 891 trials
91.7%
+5.2% vs benchmark
5%
47 trials in Phase 3/4
21%
89 of 420 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 420 completed trials
Clinical Trials (891)
Living Independence Through Functional Training
Early Cognitive Interventions in Digital Format for Cancer Survivors
Anticipating Decline and Providing Therapy
Delirium and Cognitive Impairment Development in Hospitalized Older Adults Under Isolation Conditions
Structural and Clinical Predictors of Cognitive Impairment After Surgical Treatment for Ruptured Cerebral Aneurysms
Mind Your Heart-II
Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression
Feasibility and Acceptability of StimolIrpinia for Cognitive Rehabilitation After Severe Acquired Brain Injury
Exercise and PPARGC1A rs8192678 in Older Adults With Type 2 Diabetes and Cognitive Impairment
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Effects of Accelerated rTMS on Cognitive Function
Eye-Movement Intervention for Cognitive Impairment Across Schizophrenia Spectrum
METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia
Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic
Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog
Brain Health in Breast Cancer Survivors
Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
The Care for America's Aging Study